mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.6 |
mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.6 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.7 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.7 |
mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.7 |